Three URs (ARHGAP21, KLF4, TBK1), among those that discriminated responding and non responding patients in the baseline tumor samples, lost significance in subsequent biopsies, possible reflecting the shift in the transcriptomic programs of the neoplastic lesions occurring as result of therapy. This evidence concerns the gene ARHGAP21 and neoplasm.